German Court Rules For Boston Scientific In TAVR Patent Tiff
Executive Summary
A German court has issued a preliminary ruling favoring Boston Scientific in its most recent intellectual property dispute with Edwards LifeSciences. The ruling would allow Boston Scientific to block Edwards’ Sapien 3 Ultra from the German market.
You may also be interested in...
Edwards Pays Boston Scientific $180M In TAVR Patent Settlement
Edwards Lifesciences and Boston Scientific announced this week that the firms had resolved an ongoing global patent dispute.
Boston Sci, Stryker Prevail In Long-Running Suits
Two closely watched device-world intellectual property cases moved toward a conclusion last week, as Boston Scientific triumphed over Edwards in a TAVR suit and Zimmer was ordered to pay $254m for infringing Stryker’s patent on a surgical-cleaning wand.
Latest Sapien Valve Gets EU Go-Ahead, But Germany Will Have To Wait
Edwards Lifesciences plans a "controlled rollout" of its Sapien 3 Ultra transcatheter heart valve replacement in Europe following the CE mark announced Nov. 16. But a patent dispute with Boston Scientific will prevent Edwards from launching it in Germany.